REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

I Pharmacy Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: I Pharmacy Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

I Pharmacy Sdn. Bhd. is a company based in Malaysia, with its head office in Puchong. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was first established on May 20, 2013. The company’s latest financial report indicates a net sales revenue increase of 23.55% in 2021. Over the same period, its total assets grew by 6.54%. In 2021, I Pharmacy Sdn. Bhd.’s net profit margin increased by 0.4%.

Headquarters
20G, Jalan 2/4, Bandar Puteri Puchong
Puchong; Selangor; Postal Code: 47100

Contact Details: Purchase the I Pharmacy Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the I Pharmacy Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the I Pharmacy Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the I Pharmacy Sdn. Bhd. report to view the information.
Incorporation Date:
May 20, 2013
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after I Pharmacy Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
23.55%▲
Total operating revenue
23.55%▲
Operating profit (EBIT)
31.37%▲
EBITDA
37.88%▲
Net Profit (Loss) for the Period
50.08%▲
Total assets
6.54%▲
Total equity
32.29%▲
Operating Profit Margin (ROS)
0.15%▲
Net Profit Margin
0.4%▲
Return on Equity (ROE)
2.9%▲
Quick Ratio
0.01%▲
Cash Ratio
0.1%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo